BioAtla, Inc.
BioAtla, Inc. (BCAB) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
bcab · stock forecast · 9 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 9 Wall Street analysts in the past 3 months
Buy
9 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$250
Consensus
$250
+7452.9% upside
Low
$250
Median: $250 · Last Close: $3.31
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $3.14 | ↓ 5.00% |
1-day model range: $3.07–$3.22. Peak: $3.22 (-5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | — | -50.0% |
| 2028 | — | -62.5% |
| 2029 | — | -67.2% |
| 2030 | — | -69.2% |
| 2031 | — | -70.2% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · BCAB · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-08-13 | JMP Securities | Downgrade ↓ | Market Outperform→Market Perform |
| 2025-03-31 | HC Wainwright & Co. | Maintains | Neutral→Neutral |
| 2025-03-31 | Citizens Capital Markets | Maintains | Market Outperform→Market Outperform |
| 2024-11-13 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2024-09-16 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2024-05-23 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2024-05-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-03-28 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2024-03-27 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-12-05 | JMP Securities | Maintains | Market Outperform→Market Outperform |
Wall Street analysts have recently issued updated ratings on BioAtla, Inc. (BCAB) stock. Of the recent 38 rating actions, 0 were upgrades and 3 were downgrades. 9 analysts currently cover BCAB.
Analyst Recommendation Trends
BCAB analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$3M
↓ 20.4% YoY
Revenue Next Year
$20M
↑ 587.5% YoY
EPS This Year
$-54.00
EPS Next Year
$-46.00
↓ 14.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast BCAB EPS of $-54.00 for the current fiscal year, based on estimates from 1 analysts. The BCAB revenue forecast is $3M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The BCAB stock forecast is supported by two independent data sources: analyst consensus ratings from 9 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus BCAB price target is $250.00 (+7452.9% upside), with an analyst consensus of Buy.
The BCAB short-term stock prediction for tomorrow is $3.14 (-5.00%). The BCAB stock prediction for 2030 projects a range of $1–$1.
BioAtla, Inc. trades on NASDAQ under the ticker BCAB. The BCAB stock outlook for 2027 is broadly positive, supported by a Buy consensus among 67% of covering analysts.
Frequently asked questions
BCAB forecast · 8 questionsAccording to 9 Wall Street analysts, the average 12-month BCAB price target is $250.00, with a high forecast of $250.00 and a low of $250.00. The median price target is shown in the chart above when available. This implies +7452.9% potential upside from the current price of $3.31.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.